435 related articles for article (PubMed ID: 9688985)
1. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
2. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
[TBL] [Abstract][Full Text] [Related]
5. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
7. Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats.
Hsieh TJ; Lin SR; Lee YJ; Shin SJ; Lai YH; Hsu CH; Tsai JH
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F112-21. PubMed ID: 10894793
[TBL] [Abstract][Full Text] [Related]
8. Combined effects of AT(1) and ET(A) receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats.
Pollock DM; Derebail VK; Yamamoto T; Pollock JS
Gen Pharmacol; 2000 May; 34(5):337-42. PubMed ID: 11368889
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats.
Kassab S; Miller MT; Novak J; Reckelhoff J; Clower B; Granger JP
Hypertension; 1998 Jan; 31(1 Pt 2):397-402. PubMed ID: 9453335
[TBL] [Abstract][Full Text] [Related]
10. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats.
Berthon N; Laurant P; Fellmann D; Berthelot A
J Cardiovasc Pharmacol; 2003 Jul; 42(1):24-31. PubMed ID: 12827022
[TBL] [Abstract][Full Text] [Related]
11. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
12. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
[TBL] [Abstract][Full Text] [Related]
13. ETA receptor blockade prevents hypertension associated with exogenous endothelin-1 but not renal mass reduction in the rat.
Pollock DM; Polakowski JS
J Am Soc Nephrol; 1997 Jul; 8(7):1054-60. PubMed ID: 9219154
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
15. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Johnson RJ; Galligan JJ; Fink GD
J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
[TBL] [Abstract][Full Text] [Related]
16. Enhanced renal expression of preproendothelin mRNA during chronic angiotensin II hypertension.
Alexander BT; Cockrell KL; Rinewalt AN; Herrington JN; Granger JP
Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1388-92. PubMed ID: 11294758
[TBL] [Abstract][Full Text] [Related]
17. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
18. Renal endothelin receptor type B upregulation in rats with low or high renin hypertension.
Brakch N; Abdel-Sayed S; Allemandou F; Wang Q; Aubert JF; Brunner HR; Nussberger J
J Hypertens; 2004 Sep; 22(9):1797-803. PubMed ID: 15311109
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension.
Fink GD; Johnson RJ; Galligan JJ
Hypertension; 2000 Jan; 35(1 Pt 2):464-9. PubMed ID: 10642342
[TBL] [Abstract][Full Text] [Related]
20. Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension.
Bianciotti LG; De Bold AJ
Am J Physiol Heart Circ Physiol; 2000 Jul; 279(1):H93-H101. PubMed ID: 10899045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
